Article Text

PDF
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
  1. N Viget1,
  2. G Vernier-Massouille2,
  3. D Salmon-Ceron3,
  4. Y Yazdanpanah1,4,5,
  5. J-F Colombel2
  1. 1
    Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France
  2. 2
    Service d’Hépato-gastroentérologie, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille France
  3. 3
    Service des Maladies Infectieuses, Université Paris V, Faculté Cochin, Paris, France
  4. 4
    EA 2694, Faculté de Médecine de Lille, France
  5. 5
    Laboratoire de Recherches Économiques et Sociales, CNRS URA 362, Lille, France
  1. Professor J-F Colombel, Service d’Hépato-gastroentérologie, Hôpital Claude Huriez, CHRU de Lille, 59037 Lille Cedex, France; jfcolombel{at}chru-lille.fr

Abstract

Because of the increasing use of immunosuppressive and biological drugs, the occurrence of opportunistic infections has become a key safety issue for patients with inflammatory bowel disease (IBD). Consequently, improvement of healthcare workers’ knowledge of this domain is urgent. In this review, the preventive measures that would help to reduce the rate of opportunistic infections in patients with IBD are listed, and the management of situations frequently confronting doctors is considered. In the absence of national and international recommendations, the information given here should help doctors to optimise patient outcomes.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.